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ABSTRACT
THE ASSOCIATION BETWEEN VITAMIN D AND DEPRESSION AMONG
COLLEGE-AGED WOMEN
MAY 2011
CONSTANCE MARY BARYSAUSKAS, B.S., UNIVERSITY OF NEW HAMPSHIRE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Elizabeth R. Bertone-Johnson

Approximately 15 million Americans are diagnosed with a major depressive
disorder each year, with higher rates among women and college-aged adults. Recent
research suggests a vitamin D insufficiency may be associated with an increased risk of
depression among the elderly. However, studies have not been conducted among young
women. A recent study of young adults in Massachusetts suggests that two-thirds of this
population is vitamin D deficient. We evaluated the association between dietary vitamin
D intake and serum levels of 25-hydroxyvitamin D (25(OH)D3) and history of depression
using data from the UMass Vitamin D Status Study, a cross-sectional study of 237
college-aged women. Information on depression and health-related factors was collected
by questionnaire at a single clinic visit. Dietary vitamin D intake was assessed by a Food
Frequency Questionnaire, and serum 25(OH)D3 levels were assessed in fasting blood
samples by radioimmunoassay. In multivariable analyses, we observed the suggestion of
an association between vitamin D from food sources and history of depression. For each
100 IU/day increase of dietary vitamin D there is a 13% decreased risk of depression
(95% CI: 0.6, 1.2). However, total vitamin D intake (foods and supplements combined)
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was not associated with history of depression. Compared to women in the lowest tertile
(median=51 nmol/L) of serum 25(OH)D3, women in the second tertile (median=72
nmol/L) had an 82% decreased risk of depression (95% CI: 0.04, 0.90; ptrend=0.008). The
results of this study are consistent with vitamin D as a modifiable risk factor for
depression and may inform intervention studies among college-aged women.
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CHAPTER I

INTRODUCTION

Depression is the most common disability around the world and in the United
States among men and women ages 15-44 years old.1,2 Approximately 20.9 million
American adults (9.5% of the population) suffer from at least one type of mood disorder
and almost 14.8 million Americans adults (6.7%) are diagnosed with a major depressive
disorder each year.2 Overall, there is a high prevalence of depression found in women
(6.7%, vs. 4.0% in males) and young adults 4.7% vs. 7.3% in older adults).2,3 Recent
trends show Americans are now being diagnosed with depression earlier in life compared
to previous decades.2 The average age of onset of depressive symptoms among
Americans is during the mid 20s.4
Doctors often prescribe antidepressants for the treatment of depression.
Monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), tetracyclic
antidepressants (TeCAs), selective serotonin reuptake inhibitors (SSRIs), and serotoninnorepinephrine reuptake inhibitors (SNRIs) are all commonly prescribed forms of
antidepressants. These antidepressants alter brain chemistry in an attempt to relieve
depressive symptoms, generally by increasing or decreasing the levels of specific
neurotransmitters. In recent years, antidepressant use among adults and adolescents has
increased in the United States. The National Health and Nutrition Examination Survey
estimated that antidepressant use increased from 2.5% between 1994 and 1998 to 8.1%
between 1999 and 2001. It was estimated that between 2001 and 2003, 10.1% of adults
between the years of 15 and 54 used antidepressants.5
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Depression is a highly treatable illness in most cases; however, depression is often
left untreated. Depression is associated with low mood, a decline in cognitive functions,
and decreased energy levels.3 People of low socio-economic status (SES) have a higher
rate of depression likely because of their inability to afford necessary care.6 Many people
are unlikely to seek treatment because of the social stigma tied to depression.7 If left
untreated, depression may result in a decreased quality of life, poor physical health, and
an inability to maintain daily activities.3 Friendships and family connections may suffer,
work ethics may be disrupted, and productivity may be decreased. In college-aged
women, a woman’s ability to excel and complete her education may be hindered.
Previously, studies have found that approximately 80% of people diagnosed with
depression report some level of functional impairment due to their illness.3 Depression is
linked with higher rates of alcoholism, drug use, and suicide rates.3
Researchers have identified a multitude of risk factors that increase the risk of
developing or triggering the onset of depression. Individuals are at greater risk if they are
female, have a family history of depression and/or alcoholism, had a traumatic experience
as a child, or are experiencing stressful life events.2 Low self-esteem, self-critical and
pessimistic personalities, and being of low socio-economic status are also related to the
development of depression.2 Serious chronic diseases, such as cancer, heart disease,
Alzheimer’s, and AIDS/HIV, are all associated with an increased risk of depression.2
Although the prevalence of depression is high, the exact cause is still unknown;
however, depression is believed to be a result of numerous different factors. Biological
evidence suggests that differences in brain structure, changes in hormone production, and
malfunctions of the biological feedback mechanisms that regulate neurotransmitter
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activity are involved in the development of depression.3 A new hypothesis suggests that
a vitamin D deficiency may be associated with a disruption of these biological
mechanisms and with the occurrence of depression.8
Adults over the age of 60 years old have a prevalence of insufficient vitamin D
levels between 25% and 54%. Although the prevalence may vary by geographic region
and ethnicity, vitamin D deficiencies are common throughout the United States.9 In a
recent study conducted at Boston Medical Center, Boston Massachusetts, 36% of young
adults aged 18–29 years old had insufficient levels of vitamin D. These young adults also
showed the greatest seasonal variation of vitamin D levels compared to older participants
(50+) suggesting that young adults may have an equal risk of a vitamin D deficiency
compared with older adults.10
Vitamin D deficiency (<25 nmol/L) may be a risk factor for depression and other
psychological disorders. This association may be a result of malfunctions of biological
mechanisms involved in either the neuroendocrine or central nervous systems, but
relatively little is known about these relationships.11,12 Recent research suggests that
vitamin D supplementation may have antidepressant properties and help regulate the
neuroendocrine system.13
To our knowledge, no epidemiological studies have evaluated the association
between dietary vitamin D and serum 25-hydroxyvitamin D (25(OH)D3) and the risk of
depression in college-aged women. However, three recent cohort12,14,15 and three crosssectional16-18 studies among middle-aged and older men and women found a positive
association between vitamin D deficiency and depressive symptoms, while two crosssectional studies found no association.8,11 Other studies have found an association
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between a deficiency of serum vitamin D levels and elevated parathyroid hormone (PTH)
levels which have been associated with an increased risk of depressive symptoms in
adults.12,15 PTH regulates the conversion of vitamin D into its active form; therefore,
further suggesting that increased levels of PTH is proportionate to insufficient levels of
vitamin D increasing ones risk of depression.12,15
Evaluating this relationship in young women is particularly important given that
rates of depression are higher in young adults and women as compared to older adults
and males. Therefore, we evaluated both total and dietary intake and serum 25(OH)D3
levels and the risk of depression among the University of Massachusetts Vitamin D
Status Study, a sample of 237 young, college-aged women. We also evaluated the
association between total and dietary vitamin D intake and serum 25(OH)D3 levels and
antidepressant use.
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CHAPTER II

PHYSIOLOGY OF VITAMIN D AND DEPRESSION

Several biological mechanisms may explain the relationship with vitamin D
deficiency and the risk of depression. Specifically, research scientists have proposed that
vitamin D deficiency may contribute to disruptions in the neuroendocrine and central
nervous systems.18,19
To better understand the physiology of vitamin D and depression, it is critically
important to understand the general process of vitamin D absorption and metabolism in
the human body. Vitamin D is a secosteroid hormone with target receptors all over the
body and plays an important role in many physiological processes.18,19 Vitamin D may
be produced after exposure to sunlight. First, the skin absorbs ultraviolet B radiation
which immediately converts 7-dehydrocholesterol to pre-vitamin D3, which is then
converted to vitamin D3 (cholecalciferol).19 Vitamin D3 is transported to the liver by
vitamin D binding proteins.
Vitamin D may also be absorbed from dietary intake. Foods, like milk, eggs,
cereal, and some fish for example, naturally contain or are fortified with vitamin D3.
Vitamin D3 absorbed from the diet is transported to the liver by chylomicrons.4 Vitamin
D3 is metabolized into 25(OH)D3. 25(OH)D3 is the metabolite used to assess an
individual’s vitamin D status. 25(OH)D3 is then converted into its active form, 1, 25dihydroxy vitamin D (1, 25(OH)2D [calcitriol]) by 1-α-hydroxylase enzymes in the
kidneys and other target tissues. This process is tightly regulated by parathyroid hormone
(PTH), serum calcium, and phosphorous levels to other factors. Vitamin D receptors for
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1, 25(OH)2D are found on glial cells, neurons, glucocorticoids, and other cells involved
in the regulation of cellular function, glucocorticoid signaling, and gene
transcription.4,19,20 Receptors are also found in many areas of the human brain (ie.
prefrontal cortex, hippocampus, cingulated gyrus, thalamus, hypothalamus, and
substantia nigra), all of which have been previously linked to the physiology of
depression.4
In terms of the neuroendocrinological system one mechanism potentially linking
vitamin D and depression is based on a study of humans suffering from mental illness.
Glucocorticoid levels have been found to be higher in patients suffering from major
depressive disorder and other severe mental disorders. A malfunction in glucocorticoid
signaling and the release of cortisol may be a result of low vitamin D levels.19,21
However, the exact mechanism linking glucocorticoids, vitamin D, and depression is still
unknown.19
In terms of the central nervous system mechanism, vitamin D receptors have been
found on neuron and glial cells in the hippocampus,419 which demonstrates 1-αhydroxylase activity, suggesting that these cells are capable of converting 25(OH)D into
1,25(OH)2D.4 Active receptors in the limbic system, cortex, and cerebellum regulate
behavior by potentially stimulating the release of neurotrophins, which regulate neural
development. Areas of the cerebellum that are important for cognition have been found
to produce the enzyme 1-α-hydoxylase.13 Vitamin D possibly helps in the regulation of
neurotransmission, neuroprotection, neuroimmumodulation, and nerve growth factor
synthesis.18 Therefore, a vitamin D deficiency might lead to inactivated receptors and a
disruption to the pathway that may result in depression.
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The regulation of neurotransmitters is also involved in the central nervous system.
Neurotransmitters regulate normal brain function. Abnormal levels of neurotransmitters
may lead to impairment in neural function and could potentially contribute to depression.
Antidepressants medications are designed to regulate abnormal brain function by
increasing neurotransmitter levels. Vitamin D may affect neurotransmitter function.13
1,25(OH)2D has been shown to increase the production of tyrosine hydroxylase, a
precursor to norepinephrine potentially involved in depression. Recent animal studies
also suggest that 1,25(OH)2D may influence the upregulation of glial cell line-derived
neurotrophic factors (GDNF) that influence levels of dopamine.4
In summary, there are two potential mechanisms by which vitamin D deficiency
could lead to depression. Simply, a lot is still unknown on the biological cause of
depression due to the influence of independent factors, including: hormonal, lifestyle, and
genetic factors; however, biologic research continues to suggest vitamin D may play a
role with the onset of depression.

7

CHAPTER III

EPIDEMIOLOGY OF VITAMIN D AND DEPRESSION

Within the last five years, a total of nine epidemiologic studies have assessed the
relationship between vitamin D status and the risk of depression. Studies have
prospectively,14,20 or cross-sectionally 8,9,14,22 evaluated the association between serum
vitamin D levels and depressive symptoms or cognitive function in elderly adults outside
the United States. To our knowledge, only one study has evaluated this association in
adults within the United States.11 Overall, the majority of studies found an inverse
association between vitamin D levels and depressive symptoms,9,12,14-16,18,17 though two
studies observed no association.8,11 Of the prior studies, all nine evaluated serum vitamin
D and none evaluated dietary vitamin D intake.
In a cross-sectional analysis of a population-based cohort study of 1,282
community residents between the ages of 65 and 95 years old in the Netherlands,
Hoogendijk et al.15 (2008) were the first to evaluate the association between decreased
serum 25(OH)D levels and depression status and depression severity. Study participants
were apart of the ongoing Longitudinal Aging Study in Amsterdam. Non-fasting blood
samples were obtained from all participants and a competitive binding protein assay was
used to determine serum 25(OH)D concentrations. Serum concentrations less than 20
ng/ml were considered to be vitamin D deficient. At the first follow-up, the Center for
Epidemiologic Studies-Depression (CES-D) scale was used to assess depression status
and severity. Seventy-one percent of the study population who suffered from minor
depression and 80.8% of those who suffered from major depressive disorder were
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females. Overall, 25(OH)D levels were 14% lower in the 169 participants suffering from
minor depression (mean=19 ng/ml; p<0.001) and 14% lower in the 26 participants
suffering from major depressive disorder (mean=19 ng/ml; p<0.001) compared to the
non-depressed population (mean=22 ng/ml; p<0.001). After adjustment for confounders,
including residential geographical location or the season of blood draw, serum 25(OH)D
levels were inversely associated with depressive symptoms (p-value=0.03).
This study had several limitations. First, the study population was limited to
elderly adults.15 Older adults have a higher prevalence of being depressed, and suffer
from other chronic conditions that could affect vitamin D levels. The authors did not
adjust for race, ethnicity, and socio-economic status, even though they are risk factors for
depression. Non-fasting blood samples were obtained from all women. Food
consumption prior to the blood drawing may have attenuated the assessment of average
serum vitamin D levels.
To our knowledge, Zhao et al. (2010)11 are the only researchers who evaluated the
relationship between serum vitamin D status and depression in the United States. The
authors conducted a cross-sectional study using data from the 2005-2006 National Health
and Nutrition Examination Survey (NHANES) among 3,916 participants older than 20
years of age. Depressive symptoms were assessed using the Patient Health
Questionnaire-9 (PHQ-9) diagnostic algorithm. Serum vitamin D concentrations were
measured using the DiaSorin RIA procedure. No statistically significant associations
were found for people with vitamin D serum levels of 15-20 ng/ml compared to those
with < 15 ng/ml serum vitamin D levels in terms of risk for moderate-to severe
depression (1.24; 95% CI: 0.74-2.10), major depression (1.23; 95% CI: 0.51-3.01), and
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minor depression (1.34; 95% CI: 0.79-2.28) after adjusting for age and other potential
confounders. Among the three classifications of depression, the OR decreased linearly
with increasing quartiles of 25(OH)D, although this trend was not statistically
significantly. Zhao et al. (2010)11 used similar exposure and outcome measurements,
along with a similar statistical analysis procedure to Hoogendijk et al. but found
conflicting results.
Milaneschi et al. (2010)14 studied the relationship between serum 25(OH)D and
depressive symptoms over a 6-year follow-up period of among 654 older adults (≥ 65
years) from Tuscany Italy. Participants of this population-based cohort study were a part
of the Invecchiare in Chianti, Aging in the Chianti Area (InCHIANTI) study conducted in
1998-1999. Depressive symptoms were assessed at baseline and at the 3- and 6-year
follow-up visits using the CES-D scale. Vitamin D status was measured from the fasting
blood draw at baseline and measured by the DiaSorin RIA procedure. Compared to
women with sufficient 25(OH)D levels, women with levels < 50 nmol/L at baseline had
an increase in CES-D scores (ß=2.2; SE=1.0; p=0.03) after 3 years, and further increases
after 6 years (ß=2.5; SE=1.3; p=0.05). When vitamin D status was classified as a
dichotomous variable, women with low vitamin D levels had 2.1 (SE=0.9; p=0.02) and
2.2 (SE=1.1; p=0.04) points higher CES-D scores at the 3 and 6 year follow up
respectively, compared to women with normal vitamin D levels. Women with low
vitamin D levels also had a significantly higher risk of developing depressive mood over
the follow up (HR=2.0; 95% CI: 1.2-3.2; p=0.005) as compared to women with normal
vitamin D status. This study was limited because it did not study the association in
young adults.
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To our knowledge, there are no epidemiologic studies that assessed the
association between vitamin D status and antidepressant use, a proxy for current
depression. Jorde et al.(2008)23 designed a randomized double blinded trial in Norway
which assigned 441 overweight and obese participants to 20,000 or 40,000 IU of vitamin
D or a placebo every week for one year. The Beck Depression Inventory (BDI) was used
to measure individual depression status at baseline and follow-up visits. In both
intervention groups, there was a modest but significant improvement in BDI scores after
one year (p=0.05) compared to the placebo group, suggesting that vitamin D supplements
have antidepressant qualities, although a small proportion of the study population were
depressed.
In summary, no previous studies have evaluated the association of vitamin D
status on the risk of depression in college-aged women. Other studies have found
conflicting results in older adults, but overall support the hypothesis that a deficiency of
vitamin D levels is associated with a higher risk of depression. Previous research has not
analyzed the association between dietary vitamin D intake and risk of depression.
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CHAPTER IV

SUMMARY

Depression is one of the most common psychiatric disorders across the world,
with approximately 9.5% of American adults currently experiencing depressive
symptoms. In recent years Americans are being diagnosed with depression earlier in life.
A growing body of research suggests an association between vitamin D status and the
risk of depression. The exact mechanisms involved are still unknown, but there are three
potential mechanisms by which vitamin D status could lead to depression. Although the
highest rates of depression are amongst women and young adults, epidemiologic studies
to date have focused on older populations. Most studies suggest a positive association
between vitamin D deficiencies and depressive symptoms in elderly populations around
the world. However, no epidemiologic studies have evaluated this association in collegeaged women living in the United States. Current research has been limited to serum
25(OH)D3 levels and has not assessed the association with total and dietary intake
estimated by a validated food frequency questionnaire. This is important because public
health recommendations related to vitamin D are based on increased dietary intake; as
opposed to increase sun exposure because of the skin cancer risk associated with sun
exposure. Vitamin D deficiencies and depression affect millions of Americans each year
making them both public health concerns. Understanding the potential association
between the two could help public health officials prevent both.
Therefore, we evaluated the association between total and dietary vitamin D
intake and serum 25(OH)D3 levels and the risk of depression among young women.
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CHAPTER V

HYPOTHESES AND SPECIFIC AIMS

Using a cross-sectional design, we evaluated the relationship between vitamin D
and depression among college-aged women. The following aims were addressed:

Specific Aim 1: To evaluate the association between vitamin D and the history of
depression.
Hypothesis 1a: High total vitamin D intake is associated with a decreased risk of
depression among college-age women.
Hypothesis 1b: High dietary vitamin D intake is associated with a decreased risk
of depression among college-age women.
Hypothesis 1c: High serum 25(OH)D3 levels are associated with a decreased risk
of depression among college-age women.
Specific Aim 2: To evaluate the association between vitamin D and current use of
antidepressants as a proxy for current depression.
Hypothesis 2a: High total vitamin D intake is associated with a decreased
likelihood of antidepressant use among college-age women
Hypothesis 2b: High dietary vitamin D intake is associated with a decreased
likelihood of antidepressant use among college-age women.
Hypothesis 2c: High serum 25(OH)D3 levels are associated with a decreased
likelihood of antidepressant use among college-age women.
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Specific Aim 3: To evaluate the association between vitamin D and prevalent depressive
symptoms.
Hypothesis 3a: High total vitamin D intake is inversely associated with prevalent
depressive symptoms among college-age women.
Hypothesis 3b: High dietary vitamin D intake is inversely associated with
prevalent depressive symptoms among college-age women.
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CHAPTER VI

METHODS

Study Design and Population

We conducted a cross-sectional analysis among 237 healthy, premenopausal
college-aged women, aged 18-30 years old and living in the Amherst, MA area enrolled
in the University of Massachusetts Vitamin D Status Study between March 2006 and
May 2010 (Phase One: March 2006 – May 2008 and Phase Two: September 2008 – May
2010). The Vitamin D Status Study recruited women by advertising among the
University of Massachusetts Amherst community by posting fliers, putting table tents in
the dining halls, and making classroom announcements. Women were ineligible to
participate in the study if they: (1) were pregnant or not currently menstruating; (2) were
experiencing untreated depression (only phase 1); (3) reported a history of high blood
pressure or elevated cholesterol, kidney or liver disease, bone disease such as
osteomalacia, digestive disorders, rheumatologic disease, multiple sclerosis, thyroid
disease, hyperparathyroidism, cancer, type 1 or type 2 diabetes, or polycystic ovaries; or
(4) were taking corticosteroids, anabolic steroids, anticonvulsants, cimetidine, or
propranolol. Information on demographic, lifestyle, and behavioral factors was collected
at a single clinic visit scheduled during each participant’s late luteal phase of their
menstrual cycle.24
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Exposure Assessment
Each participant’s dietary vitamin D and dietary supplement intake for the prior
two months was assessed with a 131 item food frequency questionnaire (FFQ) at the
single clinic visit. The FFQ used by the UMass Vitamin D Status Study is modified
version of the Harvard Food Frequency Questionnaire.24 The FFQ changed slightly
between phase one and phase two of the study. All FFQs were analyzed at Harvard
University, following the University of Minnesota’s NCC-Nutrient Database and the
USDA Food and Nutrient Database. Vitamin D intake was calculated by multiplying the
reported intake of each food by its portion size and its vitamin D content and then
summing the contributions for all food items together to obtain the vitamin D intake (IU
per day). Total and dietary intake of vitamin D were assessed as continuous, categorical
(tertiles determined by the sample population), and dichotomous (sufficient [≥400
IU/day] vs. insufficient [<400 IU/day]) variables (Table 1).
Each participant also provided a fasting blood sample at their clinic visit. Blood
samples were processed and stored at -80 ºC at the University of Massachusetts, within
two hours of draw. Radioimmunoassay kits from DiaSorin (MN, USA) were used to
measure serum 25(OH)D3 concentrations, a technique that was previous validated.25 A
Beckman Gamma 4000 counter (Beckman Coulter, California, USA) was used to
quantify gamma irradiation of I125 (in counts per minute; CPM), and GraphPad Prism
version 4.00 for windows (GraphPad Software, San Diego, CA) was used to convert
CPM into concentration units. Serum 25(OH)D3 levels were assessed as continuous,
categorical (tertiles determined by the sample population), and dichotomous (sufficient
[≥50 nmol/L] vs. insufficient [<50 nmol/L]) variables (Table 1).
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Validity of Exposure Assessment
The FFQ used by the UMass Vitamin D Status Study is a modified version of the
Harvard Food Frequency Questionnaire. The Harvard FFQ has been extensively
validated for use among women in the United States. In one study, four one-week diet
records and two FFQs completed over the course of a year by 173 participants were
compared to assess the FFQs reproducibility and validity. Correlation coefficients
comparing nutrient intake assessed by the two FFQs and coefficients comparing the mean
of the four diet records with intake assessed by FFQ were high and reproducible. For
example, the r for vitamin A measured by two FFQs was 0.49. The r comparing the diet
records to the second FFQ assessment was 0.41. The results indicated that a single FFQ
is both valid and reproducible for assessing micronutrient intake.26 A validation study by
Hollis et al. was previously conducted for the radioimmunoassay kit used to measure
serum 25(OH)D3 concentrations, and both within- and between-assay CVs were low
(2.2–8.6%).25

Outcome Assessment
We assessed three outcomes of interest: 1) history of depression; 2) current
antidepressant use; and 3) current depressive symptoms score among a subset of the
population. Information on the three outcomes was collected by self-report questionnaire
at the time of each participant’s one clinic visit.
To obtain information on history of depression, the first outcome of interest,
women were asked: “Have you ever had any of the following clinician-diagnosed
illnesses?” the responses included “Depression (unipolar depression)” and “Bipolar
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disorder (manic depressive illness).” A positive response to “Depression (unipolar
depression)” was interpreted as a “yes” for a history of depression, which was assessed as
a dichotomous variable during the analysis (Table 1).
To assess the second outcome of interest, information on current antidepressant
use was collected by asking women: “Are you currently taking any of the following
medications?” with the responses included “Selective serotonin reuptake
inhibitiors/SSRIs (Prozac, Zoloft, Paxil, Effector, etc.),” “Other antidepressants (Elavil,
Wellbutrin, MAOIs such as Parnate and Nardil, etc.),” “Tranquilizers (Valium,
Thorazine, Xanax, BuSpar, etc.),” and “Lithium.” A positive response to either “SSRIs”
or “Other antidepressants” will be interpreted as a “yes” for current antidepressant use,
was assessed as a dichotomous variable during the analysis (Table 1).
To assess each participant’s current level of depressive symptoms, the third
outcome of interest, women in phase two of the study (n=50) were asked additional
questions modified from the Inventory of Depression and Anxiety Symptoms scale,27
which were then used to calculate a continuous depressive symptom score. Participants
were asked twenty questions on feelings, sensations, problems and experiences during the
last two weeks, with the response options including “not at all,” “a little bit,”
“moderately,” “quite a bit,” and “extremely.” The Inventory of Depression and Anxiety
Symptoms (IDAS) was designed to assess symptoms of depression by analyzing three
large study groups (college students, psychiatric patients, and community adults).27
Current depressive score was assessed as a continuous variable in the analysis (Table 1).
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Validity of Outcome Assessment
Sanchez-Villegas et al. (2008) assessed the validity of a self-reported physician
diagnosis of depression among 133 women aged 24 – 84 using a Structured Clinical
Interview for DSM-IV (SCID-1) as the Gold Standard and they found adequate validity.
Specifically, among the participants whom self-reported a physician’s diagnosis of
depression, 74.2% was confirmed depressed, and among the participants who reported no
prior diagnosis of depression, 81% did not suffer from depression.28 Cotterchio et al.
(1997) found that there was a high agreement rate (80%) between subject- and physicianreported antidepressant use (κ = 0.60; 95% CI: 0.47-0.74) in women aged 20 – 74 years
old.29 The Inventory of Depression and Anxiety Symptoms scale has been shown to be
internally consistent, showing excellent validity compared with self-report of depression
(r=0.67; p<0.01) and interview based surveys (r=0.87; p<0.01).27

Covariate Assessment
Lifestyle and demographic factors including smoking status, use of oral
contraceptives, racial/ethnicity, and current alcohol use were collected by a self-report in
a questionnaire at the time of the clinic visit. Physical activity,30 BMI,31 alcohol use,30
smoking status,30 and use of oral contraceptives32 have been associated with depression in
previous studies. Omega-3 fatty acids,33 season,34 and BMI34 may be associated with an
individual’s vitamin D status. Weight and height were directly measured at the clinic
visit and body mass index (BMI; weight (kg)/height (m)2) was calculated. Recreational
physical activity levels were calculated using a modified version of the NHSII
questionnaire, validated within the NHS II study population.35 Specifically participants
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were asked to report the amount of time they spent each week walking, jogging, running,
bicycling, aerobics/dancing, tennis/racket sports, swimming, yoga/Pilates, and weight
training, and MET-hours per week of activity were calculated.36 The FFQ was also used
to measure omega-3 fatty acid intake.

Data Analysis Plan
Univariate Analysis
The distribution of study participants by dietary vitamin D intake and serum
25(OH)D3, and by history of depression, current antidepressant use, and depression score
were assessed.

Bivariate Analysis
We examined the distribution of covariates according to exposure status. We then
compared the distribution of covariates according to history of depression, and current
antidepressant use, using the chi-squared test. The chi-square test was used to determine
if the observed distribution fit the expected distirubution when the cell size was
sufficient, and with Fisher’s Exact test if cell counts were small (<5). We examined the
distribution of each exposure across categories of each outcome variable. Statistical
significance was defined as p < 0.05.

Multivariate Analysis
Specific Aim 1: To evaluate the association between vitamin D and the history of
depression among college age women.
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We modeled the relationship between total and dietary vitamin D intake and
serum 25(OH)D3 levels and prevalent depression using logistic regression. Multivariable
models were then built to determine a subset of variables that best predict the risk of
depression according to vitamin D status following a stepwise logistic regression
procedure. Covariates were added to the model if their addition changed the odds ratio
for the main exposure >10%. Both total and dietary vitamin D intake and serum
25(OH)D3 levels were dichotomized based on clinical recommendations, with
insufficient levels set as the reference group for each and also using tertiles. In addition,
we modeled vitamin D continuously in the multivariable regression model.

Specific Aim 2: To evaluate the association between vitamin D and current use of
antidepressants as a proxy for depression among college age women.

We modeled the relationship between total and dietary vitamin D intake and
serum 25(OH)D3 levels and current antidepressant use using multivariable logistic
regression as described for aim 1. Total and dietary vitamin D intake and serum
25(OH)D3 levels were included in the models as continuous, dichotomous, and
categorical variables as listed above.

Specific Aim 3: To evaluate the association between vitamin D and prevalent depressive
symptoms among college age women.
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We used linear regression to model the relationship between total and dietary
vitamin D intake and prevalent depressive symptoms score adjusted for potential
covariates. Total and dietary vitamin D intake was included in the model as continuous,
dichotomous, and categorical variables. Statistical significance will be defined as p <
0.05. SAS v 9.2 software was used for all analyses (SAS Institute, Inc., Cary, North
Carolina).
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CHAPTER VII

SIGNIFICANCE

To our knowledge, no epidemiological studies have evaluated the association
between dietary vitamin D and serum 25(OH)D3 and the risk of depression among young,
college-aged women. This research suggests that risk of depression may be reduced with
individual changes in dietary intake and environmental exposure to vitamin D among
young, college-aged women. Findings could inform a public health campaign to promote
a modifiable risk factor through which young, college-aged women may reduce their risk
of depression.
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CHAPTER VIII

HUMAN SUBJECT PROTECTION

The University of Massachusetts Vitamin D Status Study was approved by the
Institutional Review Board of the University of Massachusetts Amherst. To participate
in the study all participants were required to sign an informed consent form articulating
that there was no obligation to participate, was minimal risk involved, and that they could
withdrawal from the study at any time.
In an attempt to ensure subject confidentiality, each participant was assigned a
study ID. Name and addresses of each participant are kept separate from their study ID.
Information of each study participant is stored on the password protected computer
network in the School of Public Health and Health Sciences, and only study personnel
have access.
Study participants were faced with minor immediate risks associated with
participation of this study. Participants were at risk of slight pain and bruising at the
blood draw site. The risk of infection was minimal as a sterile one-time-use needle was
used. The benefits of participating in this study greatly outweighed the risk. Study
participants gained knowledge of factors influencing their individual vitamin D status,
while helping to advance understanding of vitamin D in a population underrepresented in
prior literature.
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CHAPTER IX

PERMISSION TO ACCESS DATA

I, Constance Barysauskas, have completed and passed the Human Subject’s Training
through the Collaborative Institution Training Initiative (CITI) registered with the
University of Massachusetts Amherst. Upon completion, Elizabeth Bertone-Johnson, coPrincipal Investigator of the UMass Vitamin D Status Study, granted permission to use
the UMass Vitamin D Status Study data for the purposes of this thesis.

Signed:

______________________________________
Elizabeth R. Bertone-Johnson

______________________________________
Constance Barysauskas
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CHAPTER X

RESULTS

The study population consists of 237 primarily non-Hispanic white women with a
mean age of 21.6 years old (range from 18 years to 30 years) who enrolled primarily in
the spring months at UMass. The mean BMI of the study population was 23 kg/m2
(SD=3.2). Information on total vitamin D and intake from foods were presented in Table
2. The mean total vitamin D intake was 378 IU/day (SD=298.6) and mean dietary
vitamin D intake was 214 IU/day (SD=146.6). Mean serum 25(OH)D3 levels in the 182
women for whom levels were available was 79 nmol/L (SD=31.8) (Table 2). A total of
26 women (11%) were previously diagnosed with depression and 15 women (7%) were
currently taking antidepressants at the time of enrollment (Table 3).
Characteristics of the participants by total, dietary and serum vitamin D are
described in Tables 4, 5, and 6. Omega-3 fatty acids and calcium intake were
significantly and positively related to total and dietary vitamin D intake (Table 4 and 5).
Alcohol intake was significantly higher in those women who had insufficient total
vitamin D intake and serum 25(OH)D3 levels compared to those with sufficient total
intake and serum 25(OH)D3 levels (Table 4 and 6). Physical activity was positively
related to dietary vitamin D intake (Table 5). Past and current oral contraceptive use was
associated with serum 25 (OH)D levels (Table 6). Age, race, body mass index (BMI),
education level, and current and history of smoking were not associated with total and
dietary vitamin D intake, or serum 25(OH)D3 levels.

26

BMI was significantly higher in women who had a previous diagnosis of
depression compared to those who were never diagnosed with depression (p=0.04) (Table
7). Alcohol intake was significantly higher in those participants who were not current
taking antidepressants compared to those who were (Table 8). Season was marginally
associated with history of depression and current antidepressant use (Table 7 and 8).
Age, race, education level, history of oral contraceptive use, history of smoking, physical
activity, omega-3 fatty acids, and calcium intake was not associated with a previous
diagnosis of depression and current antidepressant use.
In bivariate analyses, there was no association between dietary and total vitamin
D intake assessed continuously, dichotomously, and in tertiles and a history of depression
(Table 9). Serum 25(OH)D3 levels showed an overall significant association with history
of depression (p=0.03). Total and dietary intake and serum vitamin levels were not
associated with current antidepressant use (Table 9).
In unadjusted and adjusted analyses, dietary vitamin D intake was associated with
history of depression, though results were not statistically significant (Table 10). For
each 100 IU/day increase in dietary vitamin D there was a 17% decreased risk of
depression (95% CI: 0.61, 1.13). Compared to woman in the lowest tertile of dietary
vitamin D intake (median = 68 IU/day), the women in tertile 2 and 3 reported a lower rate
of depression (tertile 2: OR=0.86, 95% CI: 0.33, 2.25; tertile 3: OR=0.66, 95%: 0.24,
1.85; ptrend=0.89). After adjustment for energy, age, BMI, season, history of oral
contraceptive use, calcium, omega-3 fatty acids, and alcohol consumption, for each 100
IU/day increase of dietary vitamin D intake there was a 13% decreased risk of depression
(95% CI: 0.63, 1.20). After adjustment, women consuming more that 400 IU/day had a
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77% decreased risk of depression compared with women who consumed less than 400
IU/day (95% CI: 0.03, 1.84). After adjustment, woman in the lowest tertile of dietary
vitamin D intake (median = 68 IU/day) compared to women in tertile 2 and 3 showed a
lower risk of depression (tertile 2: OR=0.96, 95% CI: 0.34, 2.76; tertile 3: OR=0.78,
95%: 0.27, 2.26; ptrend=0.89).
In multivariable analyses, women in the lowest tertile of serum 25(OH)D3 levels
(median=51 IU/day), compared to women in tertile 2 (median=72) had an 82% lower risk
of depression (95% CI: 0.04, 0.90, ptrend=0.03). Risk was higher in women in tertile 3
(median=109) showed an increased risk (ORadj=1.58; (95% CI: 0.51, 4.86)) compared to
those in tertile 1 (ptrend=0.03). We could not assess the association between the
recommended daily vitamin D intake (600 IU/day) and history of depression because our
study population had overall low vitamin D intake.
In unadjusted and adjusted analyses, decreased vitamin D was associated with
current antidepressant use, though the results were not statistically significant and the
confidence intervals were wide (Table 11). Women with higher intake of dietary vitamin
D had a 48% lower risk of current antidepressant use compared to women with intake
less than 400 IU/day (95% CI: 0.07, 4.08). In multivariable analyses higher total vitamin
D intake was associated with a 31% lower risk of current antidepressant use compared to
less than 400 IU/day (95% CI: 0.22, 2.22). For every 100 IU/day increase of dietary
vitamin D intake there was a 15% lower risk of current antidepressant use (95% CI: 0.55,
1.32). Compared to women with serum 25(OH)D3 levels less than 50 nmol/L, women
with levels greater than 50 nmol/L were 48% less likely to be taking antidepressants
(95% CI: 0.12, 2.29).
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In unadjusted analyses among a small subset of the population who had
completed the IDAS depressive symptoms questionnaire, for every 100 IU/day unit
increase of total vitamin D there is a 0.02 decrease in depressive symptom score
(p=0.96); however this was not statistically significant (Table 12). Multivariable
analyses showed a 0.0003 decrease in depressive symptom score for each 100 IU/day
increase of total vitamin D (p=0.99). Every 100 IU/day increase in dietary vitamin D
intake was associated with a 0.81 increase in depressive symptom score (p=0.47), again
these findings were not statistically significant.
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CHAPTER XI

DISCUSSION

Results from this cross-sectional analysis of young college-aged women suggest
that high dietary and total vitamin D intake and high levels of serum 25(OH)D3 may be
associated with a lower risk of depression; however our findings were not statistically
significant. In some analyses, higher intake of dietary vitamin D and high levels of
serum 25(OH)D3 were inversely but not significantly associated with history of
depression in young women. Higher intake of dietary vitamin D and high levels of serum
25(OH)D3 were also inversely but not significantly associated with current antidepressant
use, but results were not consistent across all analyses. However, in a sub-analysis of 50
young women with available data, vitamin D intake was not associated with the IDAS
depressive symptoms score.
Our results are consistent with those of several prior cross-sectional and cohort
studies that reported lower levels of vitamin D are associated with an increased risk of
depression.9,12,14-18 These studies were mainly conducted in elderly adults outside of the
United States. Hoogendijk et al.,15 in their cross-sectional analysis found that depression
symptoms measured by the CED-S score was significantly associated with 25(OH)D3 in
the Longitudinal Aging Study Amsterdam. Serum 25(OH)D3 levels of participants with
major depressive disorder and minor depression were 14% lower than those of
nondepressed participants. Milaneschi et al.14 in their prospective cohort analysis found
women with low serum vitamin D had a significantly higher risk of developing a
depressive mood during the six year follow-up period (HR: 2.0; 95% CI: 1.2, 3.2; p-
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value=0.005). To our knowledge, Zhao et al.11 in their cross-sectional study found a null
relationship between vitamin D status and depression in the United States and found a
null association after adjusting for confounding factors (15-20 ng/ml of serum vitamin D
compared to < 15 ng/ml: moderate-to severe depression (1.24; 95% CI: 0.74-2.10), major
depression (1.23; 95% CI: 0.51-3.01), and minor depression (1.34; 95% CI: 0.79-2.28)).
Similarly, we found that women with 25(OH)D3 levels greater than 50 nmol/L had a 18%
decreased risk of depression compared to women with levels less than 50 nmol/L (95%
CI: 0.23, 2.96). Differences in findings between our study and that of Hoogendijk and
Milaneschi may be due to a small sample size and lack of power.
Previous research has identified several different biological mechanisms that may
explain the relationship of vitamin D deficiency and depression. Vitamin D deficiency
may contribute to disruptions in the neuroendocrine and central nervous systems, which
may lead to further disruptions in the regulation of neurotransmission, neuroprotection,
neuroimmumodulation, and the release of cortisol and neurotransmitters.13,18,24

Nondifferential Misclassification of the Exposure
Each study participant completed a validated, self-report FFQ administered at the
single clinic visit to measure intake of vitamin D from foods and supplements. Each
woman was administered the same FFQ, which was systematically analyzed at Harvard
University to reduce the potential of nondifferential misclassification of the exposure.
However, due to the complexity of reporting dietary intake during the last two months, it
was possible that the young women over- or under- reported intake of foods containing
vitamin D. This form of nondifferential misclassification of the exposure may have
biased our results towards the null. However, we believe this form of nondifferential
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misclassification is unavoidable. The FFQ we used was previously validated in a similar
population limiting measurement error; however, it was difficult to limit reporting issues.
Each subject provided a blood sample during their luteal phase of their menstrual
cycle at the clinic visit. Standard procedure was followed for each sample collection and
each sample was then aliquoted into batches. Samples were then stored under the same
conditions to minimize sources of nondifferential misclassification of the exposure and
then and vitamin D levels were assayed. All samples were tested following the same
procedure; however, laboratory error may have occurred resulting in nondifferential
misclassification of the exposure, which may have reduced the risk estimate of the
relation of vitamin D and depression. However, we expect nondifferential
misclassification in this example to be minor as the technique used for analysis has
previously been validated and we had sufficient CVs (low 25(OH)D3 CV=15.0; high
25(OH)D3 CV=11.9).
Nondifferential Misclassification of the Outcome
We assessed three different outcomes to measure depression status. First,
information on history of depression was collected by self-report questionnaire at the
single clinic visit. Cases of depression were not confirmed with physician medical
records; therefore, an under- or over-reporting of depression status may have occurred.
Depression status is closely associated with a social stigma; therefore, individuals
suffering from depression may be less likely to report their diagnosis or get diagnosed
from fear of adverse social consequences. Under-reporting of depression status could
have resulted in nondifferential misclassification of the outcome, and therefore a
decreased risk estimate of the relationship between vitamin D and depression.
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Participants may have been self-diagnosed with depression instead of by a physician,
resulting in nondifferential misclassification of the outcome. Over-reporting of
depression status may have resulted in a bias towards the null, an underestimation of the
relationship of vitamin D and depression. We believe this source of nondifferential
misclassification to be unlikely, as validation studies in similar populations have shown
that self-report of depression history is adequately valid.
In terms of the second outcome, we assessed the relationship between vitamin D
and antidepressant use as a proxy for current or recurrent depression. Current
antidepressant use was measured by self-report questionnaire at the single clinic visit and
was also not confirmed with physician medical records; therefore, an under- or overreporting of antidepressant use may have occurred. Antidepressants are not only used to
treat depression but other common disorders, resulting in a potential overestimation,
which could bias our results towards the null. While 26 women reported a history of
depression in our study population, only 15 women reported current use of
antidepressants. There are 11 women previously diagnosed with depression and not
currently taking antidepressants, these women may have been previously treated and no
longer taking medication. Therefore, an underestimation of the outcome may have
resulted in a bias towards the null, an underestimation of the risk estimate between
vitamin D and depression. We believe nondifferential misclassification in this example
to be minor.
Finally in terms of the third outcome, the Inventory of Depression and Anxiety
Symptoms (IDAS) questionnaire was administered to women participating in phase 2 of
the study. It is possible that young women over- or under-reported their depressive
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symptoms, as it is a sensitive issue. This nondifferential misclassification of the outcome
would bias our results towards the null. We believe this potential bias to be minimal as
IDAS has been previously validated.
We assessed three different measures of outcome because our study questionnaire
was not initially designed to assess the association between vitamin D status and current
depression. A history of depression, current antidepressant use, and the depressive
symptoms score each capture a different aspect of our outcome. Each outcome has its
own limitations, but together they provide general insight into the relationship between
vitamin D and depression risk.
Selection Bias
Study participants enrolled in the University of Massachusetts Vitamin D Status
Study on a volunteer basis after seeing flyers and hearing classroom announcements
around the university campus. Those who participated were likely to be healthier, had
better diets, were more motivated, and had a greater interest in personal health issues than
nonparticipants. Depressed people may have been less likely to participate in the study
because they perceive themselves as being unhealthy or were unmotivated to do so. The
mean BMI for women previously not diagnosed with depression was less than previously
diagnosed participants (BMIdepressed=24.7 kg/m2 (SD=4.5) vs. (BMInon-depressed=22.8 kg/m2
(SD=2.9)). If depressed women are more likely to stay inside their homes where they are
exposed to less sun and perceive themselves as being unhealthy, then they would be less
likely to participate in the study compared with depressed women with higher vitamin D.
This may have resulted in an underrepresentation of depressed people with a high vitamin
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D status. Therefore, this type of selection bias may have biased our results towards the
null and underestimate the association between low vitamin D status and depression.

Information Bias
Depressed young, college-aged women may have a bad personal outlook and may
report a more unhealthy diet than they actually eat or complete the questionnaire less
thoroughly. If depressed study participants reported their diets as lower quality (e.g.
lower levels of vitamin D) as compared to non-depressed participants, this would have
resulted in an information bias. This type of information bias may have biased our results
away from the null and overestimated the association between low vitamin D status and
depression. However, we believe it is unlikely that this bias occurred in this study
because our FFQ was previously validated in a similar population.

Confounding
We collected information on confounding factors through the self-report
questionnaire completed at the clinic visit. We evaluated most confounding factors
recognized in the literature. Women with hormonal and endocrine related disorders were
restricted from the study population. We did not collect information on yearly income.
Potentially, study participants of lower income may eat unhealthier and therefore have
lower vitamin D levels and tend to be depressed due to their current situation than of
women of higher income. This confounder could result in an overestimation of the
association between low vitamin D status and depression. However, we do not suspect
this to be a concern as a large proportion of our study population is students who obtain
most meals at the university dining halls. Residual confounding is possible though we
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collected information on most if not all confounding factors to control for influential
factors in our analysis between vitamin D status and depression risk.

Temporal Bias
An association between vitamin D status and depression may be difficult to
capture in a cross-sectional analyses. We were unable to determine if a vitamin D
deficiency came before the diagnosis of depression or vice versa because information on
both variables were collected at the same time. Clinically detectable depression may take
years to develop; therefore, a study participant may have been vitamin D deficient at time
of enrollment but was previously not diagnosed from depressive symptoms, but may have
been diagnosed after enrollment. In addition depression also leads to a unhealthy diet
and low physical activity levels, thus resulting in low vitamin D intake and 25(OH)D3
levels. Therefore, we were unable to determine a causal inference between vitamin D
status and depression in this cross-sectional analysis.

Survival Bias
We do not believe survivor bias was a major issue in this cross-sectional design.
If severe vitamin D deficiencies led to serious forms of depression, individuals may have
an increased risk suicide. This survivor bias would have resulted and underestimated the
association between low vitamin D and depression. However, it was unlikely that this
bias occurred in this study, because it is unlikely that such low vitamin D levels led to
suicide (a rare outcome).
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Generalizability
The results of this study could be generalized to young, college-aged
women of different racial and ethnic groups as the physiology of vitamin D and risk of
depression is likely consistent across different groups around the world. It is unclear
whether the results of our study could be generalized to men because the development of
depression may be associated with female hormones, like estrogen. The results of this
study cannot be generalized to older women because they usually suffer from multiple
chronic conditions that may also be related to vitamin D status that may be associated
with the development of depression.

Conclusions
Results from our small cross-sectional analysis suggest the possibility of an
inverse association between vitamin D status and depression. Long-term longitudinal
studies with repeated exposure and outcome assessments should be performed to further
assess whether lower total and dietary vitamin D intake and lower serum 25(OH)D3
levels are associated with the risk of depression.
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TABLES
Table 1. Classification of the study variables: UMass Vitamin D Status Study, 2006-2009

Name

Description

Type

Outcome Variables
Prev_Diag_Dep

ANTI
Depress_score

Previously Diagnosed with
Depression
0 = no
1 = yes
Current Antidepressant Use
0 = no
1 = yes
Depression Score

Dichotomous

Dichotomous
Continuous

Exposure Varaibles
vitdadj2

vitdadj1
vitd100adj

vitdadj2c

vitdadj1c
vitd100Tadj

vitd2b

vitd1b

Total Vitamin D Intake (IU/day)
1 = Tertile 1 (Median = 107)
2 = Tertile 2 (Median = 307)
3 = Tertile 3 (Median = 619)
Total Vitamin D Intake(IU/day)
0 = ≥ 400
1 = < 400
Total Vitamin D Intake (100 IU/day)
Dietary Vitamin D Intake (IU/day)
1 = Tertile 1 (Median = 68)
2 = Tertile 2 (Median = 180)
3 = Tertile 3 (Median = 350)
Dietary Vitamin D Intake(IU/day)
0 = ≥ 400
1 = < 400
Dietary Vitamin D Intake (100
IU/day)
Serum 25(OH)D3 (nmol/L)
1 = Tertile 1 (Median = 51)
2 = Tertile 2 (Median = 72)
3 = Tertile 3 (Median = 109)
Serum 25(OH)D3 (nmol/L)
0 = ≥ 50
1 = < 50
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Categorical

Categorical
Continuous

Categorical

Categorical
Continuous

Categorical

Categorical

Name

Description

Type

Exposure Variables Continued
vitd10

Serum 25(OH)D3 (nmol/L)

Continuous

Age at enrollment
Age at enrollment
1 = < 19.9 years
2 = 19.9 - 22.3 yrs
3 = > 22.3 yrs

Continuous

BMI at enrollment
BMI at enrollment
1 = <18.5
2 = 18.5-24.9
3 = 25.0-29.9
4 = ≥30.0
Education
1 = No College Degree
2 = College Degree
Race/Ethnicity
1 = White
2 = Other
Current Oral Contraceptive Use
0 = no
1 = yes
Ever Oral Contraceptive Use
0 = never
1 = ever
Currently Smoking
0 = no
1 = yes
Ever Smoke
0 = never
1 = ever
Current Alcohol Consumption (g/day)
1 = Tertile 1 (Median = 0)
2 = Tertile 2 (Median = 3)
3 = Tertile 3 (Median = 12)

Continuous

Covariates
age
cage

BMI

BMI_c

educ_d

race_d

cur_oc

ev_oc

cur_smk

ever_smk

alco2
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Categorical

Categorical

Dichotomous

Dichotomous

Dichotomous

Dichotomous

Dichotomous

Dichotomous

Categorical

Name
alco1
alco
calc2

calc1
calc
omega2

omega1
omega
season

pa_cat
pa_tot

Description
Current Alcohol Consumption (g/day)
1 = Low (Median = 2)
2 = High (Median = 12)
Current Alcohol Consumption (g/day)
Calcium Intake (IU/day)
1 = Tertile 1 (Median = 772)
2 = Tertile 2 (Median = 1285)
3 = Tertile 3 (Median = 1745)
Calcium Intake (IU/day)
0 = ≥ 1200
1 = < 1200
Calcium Intake (IU/day)
Omega-3 Fatty Acids (IU/day)
1 = Tertile 1 (Median = 0.03)
2 = Tertile 2 (Median = 0.2)
3 = Tertile 3 (Median = 0.46)
Omega-3 Fatty Acids (IU/day)
0 = ≥ 0.3
1 = < 0.3
Omega-3 Fatty Acids (IU/day)
Season at Enrollment
1 = Winter
2 = Spring
3 = Summer/Fall
Phyisical Activity (METs/week)
1 = Tertile 1 (Median = 106)
2 = Tertile 2 (Median = 177)
3 = Tertile 3 (Median = 264)
Phyisical Activity (METs/week)
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Type
Categorical
Continuous
Categorical

Categorical
Continuous
Categorical

Categorical
Continuous
Categorical

Categorical
Continuous

Table 2. Distribution of Vitamin D (n=237): UMass Vitamin D Status Study, 2006-2009

a

Serum 25(OH)D3, n=182

Table 3. Distribution of Depression (n=237): UMass Vitamin D Status Study, 2006-2009

a

Depression scale, n=50
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Table 4. Distribution of Covariates According to Total Vitamin D Intake (n=237): The
UMass Vitamin D Status Study, 2006-2009

a

p-values from chi-square tests for the categorical variables
p-values from Fisher’s Exact Test if cell count is less than 5
c
METs, metabolic equivalents

b
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Table 5. Distribution of Covariates According to Dietary Vitamin D Intake (n=237): The
UMass Vitamin D Status Study, 2006-2009

a

p-values from chi-square tests for the categorical variables
p-values from Fisher’s Exact Test if cell count is less than 5
c
METs, metabolic equivalents

b
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Table 6. Distribution of Covariates According to Serum 25(OH)D3 (n=182): The UMass
Vitamin D Status Study, 2006-2009

a

p-values from chi-square tests for the categorical variables
p-values from Fisher’s Exact Test if cell count is less than 5
c
METs, metabolic equivalents

b
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Table 7. Distribution of covariates according to history of depression (n=237): The
UMass Vitamin D Status Study, 2006-2009

a

p-values from chi-square tests for the categorical variables
p-values from Fisher’s Exact Test if cell count is less than 5
c
METs, metabolic equivalents

b
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Table 8. Distribution of covariates according to current antidepressant use (n=237): The
UMass Vitamin D Status Study, 2006-2009

a

p-values from chi-square tests for the categorical variables
p-values from Fisher’s Exact Test if cell count is less than 5
c
METs, metabolic equivalents

b
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Table 9. Distribution of vitamin D according to history of depression and current antidepressant use (n=237 [Total and Dietary
Vitamin D]; n=182 [Serum 25(OH)D3): The UMass Vitamin D Status Study, 2006-2009

a
b

p-values from chi-square tests for the categorical variables
p-values from Fisher’s Exact Test if cell count is less than 5
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Table 10. Association of vitamin D intake (n=237) and serum 25(OH)D3 (n=182) levels with history of depression: The UMass
Vitamin D Status Study, 2006-2009

a

Model adjusted for age (continuously)
Model adjusted for age (continuously), BMI (continuous), season (winter, spring, summer/fall), and ever oral contraceptive use (Y/N)
c
Model adjusted for age (continuously), BMI (continuous), season (winter, spring, summer/fall), ever oral contraceptive use (Y/N), and ever smoke (Y/N)

b
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Table 11. Association of vitamin D intake (n=237) and serum 25(OH)D3 (n=182) levels with current antidepressant use: The UMass
Vitamin D Status Study, 2006-2009

a

Model adjusted for age (continuous)
Model adjusted for age (continuous), BMI (continuous), current alcohol consumption (dichotomous)
c
Model adjusted for age (continuous), BMI (continuous), calcium (continuous), current physical activity (continuous), and current alcohol consumption
(dichotomous)
d
Model adjusted for age (continuous), current alcohol consumption (dichotomous), season (winter, spring, summer/fall), and calcium (dichotomous)

b
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Table 12. Association of vitamin D intake and the depressive symptoms score (n=50): The UMass Vitamin D Status Study, 2006-2009

a
b

p-values from t-tests for continuous variables
Model adjusted for age (continuous), BMI (continuous), current physical activity (continuous), and season (winter, spring, summer/fall)
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